Why is Parmax Pharma falling/rising?

As of 27-Oct, Parmax Pharma Ltd's stock price is currently at 34.99, reflecting an increase of 1.98, or 6.0%. The stock has shown strong performance today, outperforming its sector by 6.12%, with an intraday high of Rs 35.2, representing a 6.63% increase. However, it also experienced a low of Rs 31.03, indicating significant volatility with an intraday volatility of 6.28%. Over the past week, the stock has gained 12.29%, while it has underperformed on a year-to-date basis with a decline of 20.93%. The rising investor participation, evidenced by a 31.57% increase in delivery volume on 24 October, suggests growing interest in the stock, although no specific positive or negative factors were provided to further explain its recent movement.
Broader market context indicates that while Parmax Pharma has seen a notable rise in the short term, its performance over the last month shows a gain of 3.83%, which is lower than the Sensex's increase of 5.41%. This suggests that while the stock is experiencing a positive trend recently, it still lags behind the broader market performance. The stock's year-to-date and one-year returns are significantly negative compared to the Sensex, which has gained 8.50% and 6.77% respectively, highlighting the challenges Parmax Pharma faces in the longer term despite its recent gains.